Introduction
Thymic malignancies are rare tumors with mainly local extensions and/or recurrences. Thymic carcinomas account for less than 1-4% of thymic epithelial tumors. The most common sites of metastatic thymic carcinomas (Masaoka-Koga stage IVb) are the lung, liver and brain. Unusual metastatic sites have been reported. They can be found in the kidney, pancreas, pituitary, orbital, lymph nodes, peritoneum, and the ovaries.
Case Report
Thymoma B3 was diagnosed in a 64-year-old female in 2002 ( fig. 1 ). According to the French RYTHMIC guidelines, the patient underwent preoperative chemo-radiotherapy followed by a complete resection [1] . Parietal and pleural tumors were detected by CT scan and [ 18 F]FDG-PET/CT in 2008. The patient was reoperated, and these tumors were confirmed to be metastases of mixed thymoma B3 and thymic carcinoma. A pelvic mass was detected in 2013 by [ 18 F]FDG-PET/CT (SUVmax 8.4) and confirmed by MRI ( fig. 2, fig. 3 ). The patient was asymptomatic. A laparotomy confirmed an isolated peritoneal 60-mm tumoral mass localized on the left part of the Douglas's pouch. The lesion was completely resected. Pathological analysis concluded metastasis of the previously diagnosed thymic carcinoma ( fig. 4 ).
Discussion
Peritoneal and/or ovarian metastasis from thymic malignancies are very rare; only four cases have been reported in the literature [2] [3] [4] . These metastases can occur immediately or several years after primary thymic tumor (3-6 years). Different thymic histological subtypes were observed (carcinoma, B1, neuroendocrine), and they were always associated with a loco-regional extension and/or distant metastasis. To our knowledge, this is the first report of an isolated pelvic metastasis from thymic carcinoma. This isolated pelvic metastasis probably had a systemic origin rather than a direct peritoneal extension below the diaphragm (as described in previously reported cases). However, considering that this pelvic metastasis was isolated and completely resected, chemotherapy was not performed in our patient. Efficacy of [18F]FDG-PET/CT for the detection and localization of mediastinal recurrence is well established [5] . Our case report emphasizes the utility of [18F]FDG-PET/CT for metastasis detection and long-term follow-up in patients with thymic epithelial tumors.
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